(Q39165033)

9 September 2017

FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells (English)

1 reference

9 September 2017

0 references

16

Cynthia Hawkins

1 reference

9 September 2017

Branavan Manoranjan

1

1 reference

9 September 2017

Xin Wang

2

1 reference

9 September 2017

Robin M Hallett

3

1 reference

9 September 2017

Chitra Venugopal

4

1 reference

9 September 2017

Stephen C Mack

5

1 reference

9 September 2017

Nicole McFarlane

6

1 reference

9 September 2017

Sara M Nolte

7

1 reference

9 September 2017

Katrin Scheinemann

8

1 reference

9 September 2017

Thorsteinn Gunnarsson

9

1 reference

9 September 2017

John A Hassell

10

1 reference

9 September 2017

Michael D Taylor

11

1 reference

9 September 2017

Cathy Lee

12

1 reference

9 September 2017

Joanna Triscott

13

1 reference

9 September 2017

Colleen M Foster

14

1 reference

9 September 2017

Christopher Dunham

15

1 reference

9 September 2017

Sandra E Dunn

17

1 reference

9 September 2017

Sheila K Singh

18

1 reference

9 September 2017

1 July 2013

1 reference

9 September 2017

1 reference

9 September 2017

31

1 reference

9 September 2017

7

1 reference

9 September 2017

1266-1277

1 reference

Medulloblastoma in childhood: new biological advances

9 September 2017

1 reference

Medulloblastoma: signalling a change in treatment

21 January 2018

1 reference

Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma

21 January 2018

1 reference

Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease

21 January 2018

1 reference

Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification.

21 January 2018

1 reference

Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome

21 January 2018

1 reference

Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features

21 January 2018

1 reference

Medulloblastoma comprises four distinct molecular variants

21 January 2018

1 reference

Prediction of central nervous system embryonal tumour outcome based on gene expression

21 January 2018

1 reference

Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations

21 January 2018

1 reference

beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee

21 January 2018

1 reference

Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics

21 January 2018

1 reference

Molecular subgroups of medulloblastoma: the current consensus

21 January 2018

1 reference

Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci

21 January 2018

1 reference

Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice.

21 January 2018

1 reference

Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449

21 January 2018

1 reference

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas

21 January 2018

1 reference

An animal model of MYC-driven medulloblastoma

21 January 2018

1 reference

A mouse model of the most aggressive subgroup of human medulloblastoma

21 January 2018

1 reference

FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma

21 January 2018

1 reference

Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas

21 January 2018

1 reference

The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance.

21 January 2018

1 reference

Clinical outcome in pediatric glial and embryonal brain tumors correlates with in vitro multi-passageable neurosphere formation

21 January 2018

1 reference

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

21 January 2018

1 reference

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

Identification of human brain tumour initiating cells

21 January 2018

1 reference

Mammalian neural stem cells

21 January 2018

1 reference

Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell.

21 January 2018

1 reference

Neurosphere formation is an independent predictor of clinical outcome in malignant glioma

21 January 2018

1 reference

Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis.

21 January 2018

1 reference

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

21 January 2018

1 reference

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

21 January 2018

1 reference

Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.

21 January 2018

1 reference

Sonic hedgehog regulates Bmi1 in human medulloblastoma brain tumor-initiating cells.

21 January 2018

1 reference

Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells

21 January 2018

1 reference

Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma

21 January 2018

1 reference

Multipotent CD15+ cancer stem cells in patched-1-deficient mouse medulloblastoma

21 January 2018

1 reference

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

21 January 2018

1 reference

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

Bmi-1 cooperates with Foxg1 to maintain neural stem cell self-renewal in the forebrain

21 January 2018

1 reference

The neural progenitor-specifying activity of FoxG1 is antagonistically regulated by CKI and FGF.

21 January 2018

1 reference

Crypt stem cells as the cells-of-origin of intestinal cancer

21 January 2018

1 reference

Musashi1, an evolutionarily conserved neural RNA-binding protein, is a versatile marker of human glioma cells in determining their cellular origin, malignancy, and proliferative activity.

21 January 2018

1 reference

The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network

21 January 2018

1 reference

NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation

21 January 2018

1 reference

Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.

21 January 2018

1 reference

Induction of neural stem cell-like cells (NSCLCs) from mouse astrocytes by Bmi1.

21 January 2018

1 reference

Expression analysis of stem cell-related genes reveal OCT4 as a predictor of poor clinical outcome in medulloblastoma.

21 January 2018

1 reference

Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor.

21 January 2018

1 reference

Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile

21 January 2018

1 reference

Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas.

21 January 2018

1 reference

Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas

21 January 2018

1 reference

Telomerase activity-independent function of TERT allows glioma cells to attain cancer stem cell characteristics by inducing EGFR expression

21 January 2018

1 reference

Telomere maintenance in childhood primitive neuroectodermal brain tumors

21 January 2018

1 reference

Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition

21 January 2018

1 reference

TWIST1 promotes invasion through mesenchymal change in human glioblastoma

21 January 2018

1 reference

Subtypes of medulloblastoma have distinct developmental origins

21 January 2018

1 reference

A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs

21 January 2018

1 reference

FOXG1 dysregulation is a frequent event in medulloblastoma

21 January 2018

1 reference

Subgroup-specific structural variation across 1,000 medulloblastoma genomes

21 January 2018

1 reference

Overexpression of FOXG1 contributes to TGF-beta resistance through inhibition of p21WAF1/CIP1 expression in ovarian cancer

21 January 2018

1 reference

shRNA knockdown of Bmi-1 reveals a critical role for p21-Rb pathway in NSC self-renewal during development

21 January 2018

1 reference

Bmi1 directly represses p21Waf1/Cip1 in Shh-induced proliferation of cerebellar granule cell progenitors.

21 January 2018

1 reference

Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation

21 January 2018

1 reference

Bmi1 marks intermediate precursors during differentiation of human brain tumor initiating cells.

21 January 2018

1 reference

Clinical and molecular stratification of disease risk in medulloblastoma

21 January 2018

1 reference

The origins of medulloblastoma subtypes

21 January 2018

1 reference

Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/STEM.1401

1 reference

9 September 2017

1 reference